Exit watch, week of May 3, 2010

Apple scoops up VC-backed Siri, Intrinsity

Apple Inc. last week bought Siri Inc., maker of an iPhone assistant. No financial terms were disclosed. Siri had raised $24 million in venture funding from Menlo Ventures, Morganthaler Ventures and SRI International. This includes a $15.5 million Series B round last November.

Separately, Apple also acquired Intrinsity Inc., an Austin, Texas-based provider of high-speed, low-power embedded processor cores. No financial terms were disclosed. Intrinsity had raised more than $80 million over five rounds of venture funding from Goldman Sachs, Altitude Capital Partners, Northwater Capital Management, Adams Capital Management and The Hillman Co.

Silicon Labs snatches Silicon Clocks

Silicon Labs (Nasdaq: SLAB) has acquired Silicon Clocks, a Fremont, Calif.-based provider of integrated timing solutions for electronic systems. No financial terms were disclosed. Silicon Clocks had raised over $32 million in VC funding from Silicon Labs, Charles River Ventures, Formative Ventures, Lux Capital and Tallwood Venture Capital.

Attensity acquires Biz360

Attensity Group

, a business intelligence and information management platform, has acquired Biz360 Inc., a San Mateo, Calif.-based provider of media and market intelligence solutions. No financial terms were disclosed, except that Biz360 shareholders will hold a stake in the combined company. Biz360 raised nearly $50 million in total VC funding, including a late 2006 recap. Backers include Foundation Capital, Granite Ventures and Scale Venture Partners. Attensity was formed last year as a rollup of three businesses, one of which raised more than $30 million from firms that include Highway 12 Ventures, Palomar Ventures, Jefferson Partners, RD Webber, Triangle Venture Capital and Village Ventures.

French company buys RedPath Integrated for $32M

ExonHit Therapeutics SA

, a listed French therapeutics company, has agreed to acquire RedPath Integrated Pathology Inc., a Pittsburgh-based cancer diagnostics company. The deal is valued at upwards of $32 million, including up-front payments of $12.5 million in cash and $10 million in stock. RedPath had raised more than $10 million in VC funding from Seneca Health Partners, Inflexion Partners, HMA Capital Partners, New Spring Capital and CID Capital.